Bob Rhatigan's guest appearances

Bob Rhatigan

Beauty Bytes with Dr. Kay: Secrets of a Plastic Surgeon™

Aesthetics Innovators Podcast

Next Level Practices

Technology of Beauty

Whitney Bell

Chalene Johnson

Rupa Wong

Danielle Belardo

Brittany Krystle

Daniel Amen

Teddi Mellencamp

Luke Storey

Kaitlyn Herman

Brittany Hicks

Jeff Castillo

Christina Meyer

Candace Burch

Jenna Ushkowitz

Maxim Model Victoria Barbara

OwlTail

Happy Tuesday, beauties! On this week's episode, I introduce you to CEO of Merz North America, Bob Rhatigan! I had the pleasure of podcasting with Bob a couple weeks ago at the Merz Aesthetics Expert Summit where I was on a panel discussing the future of aesthetics. Merz is the maker of some of my favorite products like Belotero, Radiesse, and Xeomin. If you're following me on Instagram, you may have seen me using Radiesse to contour the cheeks or Xeomin when its time for toxins every few months. Merz has been family owned for generations and their presence within the aesthetics marketplace continues to grow as more patients become well informed about the array of products available today. In this episode, Bob chats with me about the Later Haters campaign, the future of Merz, and some of his tips for success.   Find me on Instagram here Find Merz on Instagram here Watch a video of Jawline filler using Radiesse here Shop my amazing skincare line here

Happy Tuesday, beauties! On this week's episode, I introduce you to CEO of Merz North America, Bob Rhatigan! I had the pleasure of podcasting with Bob a couple weeks ago at the Merz Aesthetics Expert Summit where I was on a panel discussing the future of aesthetics. Merz is the maker of some of my favorite products like Belotero, Radiesse, and Xeomin. If you're following me on Instagram, you may have seen me using Radiesse to contour the cheeks or Xeomin when its time for toxins every few months. Merz has been family owned for generations and their presence within the aesthetics marketplace continues to grow as more patients become well informed about the array of products available today. In this episode, Bob chats with me about the Later Haters campaign, the future of Merz, and some of his tips for success. Find me on Instagram <a href="http://instagram.com/beautybydrkay" rel="nofollow" target="_blank">here</a> Find Merz on Instagram <a href="https://www.instagram.com/merz_aesthetics/?hl=en" rel="nofollow" target="_blank">here</a> Watch a video of Jawline filler using Radiesse <a href="https://www.youtube.com/watch?v=ejPD8cAEf5U" rel="nofollow" target="_blank">here</a> Shop my amazing skincare line <a href="http://beautybydrkay.com/shop" rel="nofollow" target="_blank">here</a>

186: Xeomin, Marketing, & Stigmas with Merz North America CEO, Bob Rhatigan

Christie Brinkley

In this Aesthetics Innovators Podcast episode, Bob Rhatigan, CEO of Merz Americas, talks with co-host Grant Stevens, MD, about the battle building in the toxin market, including Merz’s own Xeomin. Is the risk of commoditization real? Rhatigan also discusses several of the company’s effective marketing plans to target “Reclaimers” and to tout the effectiveness of skin-tightening tool Ultherapy with a campaign highlighting Christie Brinkley.  Rhatigan will be pulling double duty at the upcoming Aesthetics Innovation Summit, sitting on our panels, “Clash of the Toxin Titans, Part II” and “What Investors Are Looking for in Aesthetics.” In this interview, Rhatigan discusses Merz’s in-house venture program. “We don’t just want to provide seed money,” he says. “We want to provide intellectual value.” Speaking of the May 15 Aesthetics Innovation Summit, Rhatigan says he’s excited by the potential networking opportunities based on last year’s successful event. “We’ve got the physician base there. Industry is there. The investment capital folks are there,” he says. "For us in medical aesthetics, innovation really stems from strong collaboration and communication.”

In this Aesthetics Innovators Podcast episode, Bob Rhatigan, CEO of Merz Americas, talks with co-host Grant Stevens, MD, about the battle building in the toxin market, including Merz’s own Xeomin. Is the risk of commoditization real? Rhatigan also discusses several of the company’s effective marketing plans to target “Reclaimers” and to tout the effectiveness of skin-tightening tool Ultherapy with a campaign highlighting Christie Brinkley.  Rhatigan will be pulling double duty at the upcoming Aesthetics Innovation Summit, sitting on our panels, “Clash of the Toxin Titans, Part II” and “What Investors Are Looking for in Aesthetics.” In this interview, Rhatigan discusses Merz’s in-house venture program. “We don’t just want to provide seed money,” he says. “We want to provide intellectual value.” Speaking of the <a href="https://attendais.com/" rel="nofollow" target="_blank">May 15 Aesthetics Innovation Summit</a>, Rhatigan says he’s excited by the potential networking opportunities based on last year’s successful event. “We’ve got the physician base there. Industry is there. The investment capital folks are there,” he says. "For us in medical aesthetics, innovation really stems from strong collaboration and communication.”

Merz Americas’ CEO Bob Rhatigan Discusses Reclaimers, Toxin Commoditization, and Christie Brinkley